LATE-BREAKING ABSTRACT: High expression of Midkine in the airways of patients with cystic fibrosis

S. Jovic, S. Nordin, A. Egesten (Lund, Sweden)

Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Session: Cystic fibrosis: basic and applied science
Session type: Poster Discussion
Number: 2101
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Jovic, S. Nordin, A. Egesten (Lund, Sweden). LATE-BREAKING ABSTRACT: High expression of Midkine in the airways of patients with cystic fibrosis. Eur Respir J 2013; 42: Suppl. 57, 2101

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016

LATE-BREAKING ABSTRACT: The heterogeneity of systemic inflammation in bronchiectasis
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015

LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015



The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014


Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

LATE-BREAKING ABSTRACT: Socio-economic status does not influence lung function decline in children with cystic fibrosis in Australia
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


LATE-BREAKING ABSTRACT: Age-related PINK1 deficiency promotes mitochondria dysfuntion, epithelial injury and fibrosis in the lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

LATE-BREAKING ABSTRACT: Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional status
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


LATE-BREAKING ABSTRACT: Inspiratory capacity in cystic fibrosis – A silent predictor of lung deterioration
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

LATE-BREAKING ABSTRACT: The impact of a persistent bacterial bronchitis on the pulmonary microbiome of children
Source: International Congress 2016 – Paediatric respiratory infection and immunology
Year: 2016


Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment?
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


LATE-BREAKING ABSTRACT: Distribution of vitamin C transporters in the lower airways of humans
Source: Annual Congress 2013 –New molecular and cell biology mechanisms
Year: 2013


Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015